Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6.65M | $367.0M | 13.87% | -- | 2026-06-30 |
| FMR LLC | 5.32M | $293.0M | 11.10% | +2.39M | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.98M | $274.0M | 10.38% | +1.79M | 2026-06-30 |
| NEA Management Company, LLC | 3.61M | $199.0M | 7.54% | -- | 2026-06-30 |
| ORBIMED ADVISORS LLC | 3.43M | $189.0M | 7.15% | -209.2K | 2026-06-30 |
| BlackRock, Inc. | 3.32M | $183.0M | 6.93% | +382.3K | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 2.51M | $138.0M | 5.23% | -- | 2026-06-30 |
| NVP ASSOCIATES, LLC | 2.14M | $117.0M | 4.46% | -- | 2026-06-30 |
| Deep Track Capital, LP | 1.73M | $95.0M | 3.61% | -1.02M | 2026-06-30 |
| Polar Capital Holdings Plc | 1.61M | $88.0M | 3.35% | -13.7K | 2026-06-30 |
